MustGrow Biologics Can’t Be Ignored – Sold-Out Demand, Expanding Markets, Real Impact

The ‘International Investment Forum’ – (‘IIF’) provides information on investment trends and ideas, covering all aspects of various industries, from top executives and managers around the world. Join Lyndsay Malchuk on Market Frontlines for a no-nonsense conversation with Colin Bletsky, Chief Operating Officer of MustGrow Biologics. This is a story of real products meeting real demand. Discover how MustGrow has successfully transitioned from deep R&D and over 100 patents into a commercial force, with its flagship product TerraSante sold out and accelerating revenue. We cut through the hype in agricultural technology to explore what truly matters: field efficacy, farmer adoption, and scalable execution. Learn how MustGrow's unique mustard-based platform competes directly with synthetic chemicals, its strategic partnership with Bayer, and how it's capturing market share in the $380 billion global agriculture market’s fastest-growing segment: biologicals.